
Dec 23 (Reuters) - A patient who was being treated with Pfizer's hemophilia drug, Hympavzi, as part of a long-term study died after experiencing serious side effects, the company said.
The individual died on December 14 after suffering a stroke followed by a brain hemorrhage, according to the European Haemophilia Consortium, a patient support group.
The patient was enrolled in a study that was testing Hympavzi in patients with hemophilia A or B with or without inhibitors.
"Pfizer, together with the trial investigator and the independent external Data Monitoring Committee, are actively gathering information to better understand the complex, multi-factorial circumstances surrounding this occurrence," the company said in a statement.
The therapy, a once-a-week injection, gained U.S. approval last year to prevent or reduce bleeding episodes in hemophilia A or B patients aged 12 years and older by targeting blood-clotting proteins.
Pfizer does not anticipate any impact to safety for patients treated with the drug based on its current knowledge and the overall clinical data collected to date, the company said.
People with hemophilia have a defect in a gene that regulates the production of proteins called clotting factors, causing spontaneous and severe bleeding following injuries or surgery.
Earlier this year, Pfizer said it would halt global development and commercialization of its hemophilia gene therapy, Beqvez, citing soft demand from patients and their doctors.
Beqvez, a one-time therapy, was approved in the U.S. for the treatment of adults with moderate to severe hemophilia B.
(Reporting by Sneha S K in Bengaluru; Editing by Anil D'Silva)
latest_posts
- 1
Find the Excellence of Old style Expressive dance: Encountering the Effortlessness and Polish of Dance - 2
Believe Should Unwind? Look at These Scaled down Games - 3
Netanyahu on Gush Etzion terror attack: 'We will complete war on all fronts' - 4
The most effective method to Integrate Compact disc Rates into Your Retirement Arranging - 5
You finally got a doctor's appointment. Here's how to get the most out of it
What is Fusarium graminearum, the fungus a Chinese scientist pleaded guilty to smuggling into the US?
She's been a Bond girl and a mutant. Now she's grappling with Hollywood's obsession with 'eternal youth.'
German Court Rejects Bid To Force BMW and Mercedes-Benz To Stop Selling New Combustion-Engine Cars After 2030
I spent the last year transforming my life. Becoming a Rockette for a day made me confront a fear I couldn't shake.
As tetanus vaccination rates decline, doctors worry about rising case numbers
Must-Have Cooking Machine in Your Kitchen
Watch Atlas V rocket launch its heaviest-ever payload early on April 4
Reconnecting with an old friend is a story of distance, loss and rediscovery
JFK's granddaughter reveals terminal cancer diagnosis, criticizes cousin RFK Jr.













